Browsing: Clinical > Antimicrobial Resistance
This editorial presents some of the latest evidence to support the antivirulence approach, highlighting at the same time some of the issues that need to be considered when evaluating antivirulence drugs.
In this podcast Dr Elizabeth Whittaker, Dr James Seddon, Dr Pete Dodd and Professor Beate Kampmann discuss their work in pediatric tuberculosis focusing on the areas of immunology, modelling and drug resistance.
Take a look at our new infographic, developed for World Tuberculosis Day, which explores the facts about current TB burden, the issues around drug resistance, and research and development moving forwards.
In this original research article, the authors determine the structural contributions of a compound set containing inhibitors of bacterial enzyme FabI.
With TB still presenting a major health problem across the globe, we spoke to Timothy Rodwell about the challenges currently facing TB diagnostics and his work as acting head of the TB Program at FIND.
In this interview to mark World TB Day Madhukar Pai discusses the challenges surrounding TB case detection and the future of TB diagnostics.
Study demonstrates the value of phage therapy in effectively treating Pseudomonas aeruginosa infections.
Mark Blaskovich, Principal Investigator and Program Coordinator for the Community for Open Antimicrobial Drug Discovery (CO-ADD) discusses his work towards uncovering compounds with antibiotic potential and shares his thoughts on the best strategies to tackle antibiotic resistance moving forwards.